Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography–tandem mass spectrometry
- 1 September 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 856 (1-2), 252-260
- https://doi.org/10.1016/j.jchromb.2007.06.007
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A simple and rapid liquid chromatography method for simultaneous determination of zidovudine and nevirapine in plasmaJournal of Chromatography B, 2006
- Field Performance of a Thin-Layer Chromatography Assay for Detection of Nevirapine in Umbilical Cord BloodHIV Research & Clinical Practice, 2006
- Pharmacokinetics of Nevirapine: Once-Daily Versus Twice-Daily Dosing in the 2NN StudyHIV Research & Clinical Practice, 2005
- A validated new method for nevirapine quantitation in human plasma via high-performance liquid chromatographyBiomedical Chromatography, 2005
- High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasmaJournal of Chromatography B, 2004
- Sensitive Enzyme Immunoassay for Measuring Plasma and Intracellular Nevirapine Levels in Human Immunodeficiency Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2004
- Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding siteBiochemistry, 1991
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- A Selective Radioimmunoassay for the Determination of Pirenzepine in Plasma and UrineTherapeutic Drug Monitoring, 1987